Recital 18, Regulation (EU) 2023/741

In forcesince 5 Apr 2023

Commission Implementing Regulation (EU) 2023/116 [Commission Implementing Regulation (EU) 2023/116 of 16 January 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval period of the active substance oxamyl (OJ L 15, 17.1.2023, p. 15).] extends the approval period of oxamyl to 31 October 2023 in order to allow the renewal process to be completed before the expiry of the approval period. However, given that a decision on the non-renewal of the approval has been taken ahead of that extended expiry date, this Regulation should apply earlier than that date.